format correct. Now, researchers reveal that the glazing on ceramic tea sets plays Catrchins crucial role in retaining the beneficial Green tea polyphenol epigallocatechingallate alleviates nonalcoholic fatty liver disease and ameliorates intestinal immunity in mice fed a high-fat diet.

Liver health catechins -

Thus, these parameters were not significantly altered by tea catechins in most human studies, although they were significantly reduced in the rodent studies.

Of note, the study duration may be important when considering alterations in metabolic syndrome markers. In reviewing the studies in Table 2 , it appears that short-term studies reported no change in glucose and insulin, where treatment was administered for less than 6 weeks [ 51 ] [ 52 ].

On the other hand, longer study durations were associated with changes in glucose, insulin, and IR [ 45 ] [ 48 ] [ 53 ] [ 55 ]. Taken together, treatment with GTE should preferably be continued for at least 12 weeks, to observe effects on carbohydrate metabolites.

As can be seen from Table 2 , only five studies assayed inflammatory markers, with no conclusive trends [ 45 ] [ 46 ] [ 49 ] [ 53 ] [ 57 ]. Others reported that catechins have anti-inflammatory properties that suppress leukocyte adhesion to endothelium and inhibit transcription factors for cytokines and adhesion molecules, in other disease contexts.

In contrast to rodent studies, few studies have examined the effects of EGCG on inflammatory markers in NAFLD, highlighting the need for more research examining inflammatory profiles in patients with NAFLD.

An insufficient number of studies evaluated the effects of EGCG or GTE on oxidative stress markers. MDA and total antioxidant status TAS were the only oxidative stress markers assayed. MDA is the most frequently used biomarker of oxidative stress in various diseases [ 59 ]. TAS has an inverse relationship with other oxidative stress markers, such as MDA, as it represents antioxidative capacity [ 60 ].

Two of three studies reported significant decreases in MDA [ 40 ] [ 50 ] , and both studies investigating the effects of GTE on TAS reported significant increases [ 53 ] [ 54 ].

Basu et al. reported a significant decrease in MDA, confirming the antioxidant properties of GTE, and Bogandaski et al. reported a significant increase in TAS after 3-month supplementation with GTE, indicating that GTE improved oxidative stress [ 50 ] [ 53 ].

The antioxidative properties of green tea catechins are best appreciated by understanding the structural properties of EGCG. These properties have been attributed to the presence of dihydroxyl or trihydroxyl groups on the B-ring and meta-5,7-dihydroxyl groups on the A-ring.

The polyphenolic structure of green tea catechins allows delocalization of electrons, which promotes the elimination of reactive oxygen and nitric radicals [ 54 ]. Although limited studies have examined the effects of EGCG or GTE in humans, the available data suggest that EGCG or GTE supplementation is a promising strategy for alleviating oxidative stress.

The results of human studies are consistent with those of rodent studies, which clearly demonstrates the antioxidant effects of EGCG. Nevertheless, more research is necessary to confirm the efficacy of these supplements in reducing oxidative stress in humans.

Similar to rodent studies, serum AST and ALT were common metrics used for assessing liver damage in human studies, and both markers were decreased with EGCG and GTE treatment Table 2. Following EGCG or GTE administration, significant decreases in AST were reported in four of six studies [ 45 ] [ 55 ] [ 57 ] , and significant decreases in ALT were reported in three of five studies [ 45 ] [ 56 ] [ 57 ].

Pezeshki et al. This result was confirmed by Hussain et al. References Smith, B. Non-alcoholic fatty liver disease. Kneeman, J. Secondary causes of nonalcoholic fatty liver disease.

Younossi, Z. The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe. Hepatology , 64, — Beaton, M. Current treatment options for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Sakata, R. Green tea with high-density catechins improves liver function and fat infiltration in non-alcoholic fatty liver disease NAFLD patients: A double-blind placebo-controlled study.

Wolfram, S. Effects of Green Tea and EGCG on Cardiovascular and Metabolic Health. Raederstorff, D. Effect of EGCG on lipid absorption and plasma lipid levels in rats.

Fiorini, R. Liver Transplant. Kuzu, N. Epigallocatechin gallate attenuates experimental non-alcoholic steatohepatitis induced by high fat diet. Bose, M.

The Major Green Tea Polyphenol, - -EpigallocatechinGallate, Inhibits Obesity, Metabolic Syndrome, and Fatty Liver Disease in High-Fat—Fed Mice. Lee, M. Green Tea — -EpigallocatechinGallate Reduces Body Weight with Regulation of Multiple Genes Expression in Adipose Tissue of Diet-Induced Obese Mice.

Ueno, T. Epigallocatechingallate improves nonalcoholic steatohepatitis model mice expressing nuclear sterol regulatory element binding protein-1c in adipose tissue. Chen, N. Green tea, black tea, and epigallocatechin modify body composition, improve glucose tolerance, and differentially alter metabolic gene expression in rats fed a high-fat diet.

Chen, Y. Food Chem. Sae-Tan, S. Food Funct. Sugiura, C. Catechins and Caffeine Inhibit Fat Accumulation in Mice through the Improvement of Hepatic Lipid Metabolism. Sumi, T. SpringerPlus , 2, Kochi, T.

Non-alcoholic steatohepatitis and preneoplastic lesions develop in the liver of obese and hypertensive rats: Suppressing effects of EGCG on the development of liver lesions.

Cancer Lett. Xiao, J. Krishnan, T. EGCG mediated downregulation of NF-AT and macrophage infiltration in experimental hepatic steatosis. Gan, L. Green tea polyphenol epigallocatechingallate ameliorates insulin resistance in non-alcoholic fatty liver disease mice.

Acta Pharmacol. Ding, Y. Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet. Santamarina, A.

Decaffeinated green tea extract rich in epigallocatechingallate prevents fatty liver disease by increased activities of mitochondrial respiratory chain complexes in diet-induced obesity mice. Mi, Y. EGCG ameliorates diet-induced metabolic syndrome associating with the circadian clock. Acta Mol.

Basis Dis. Huang, J. Green Tea Polyphenol EGCG Alleviates Metabolic Abnormality and Fatty Liver by Decreasing Bile Acid and Lipid Absorption in Mice. Food Res. Yang, Z. Coadministration of epigallocatechingallate EGCG and caffeine in low dose ameliorates obesity and nonalcoholic fatty liver disease in obese rats.

Li, Y. Sheng, L. FASEB J. Li, F. EGCG Reduces Obesity and White Adipose Tissue Gain Partly Through AMPK Activation in Mice. Ushiroda, C. Green tea polyphenol epigallocatechingallate improves gut dysbiosis and serum bile acids dysregulation in high-fat diet-fed mice.

Hou, H. Epigallocatechin Gallate Suppresses Inflammatory Responses by Inhibiting Toll-like Receptor 4 Signaling and Alleviates Insulin Resistance in the Livers of High-fat-diet Rats.

Oleo Sci. Dey, P. Epigallocatechin gallate but not catechin prevents nonalcoholic steatohepatitis in mice similar to green tea extract while differentially affecting the gut microbiota. Ning, K. Epigallocatechin Gallate Protects Mice against Methionine—Choline-Deficient-Diet-Induced Nonalcoholic Steatohepatitis by Improving Gut Microbiota to Attenuate Hepatic Injury and Regulate Metabolism.

ACS Omega , 5, — Yuan, H. The phytochemical epigallocatechin gallate prolongs the lifespan by improving lipid metabolism, reducing inflammation and oxidative stress in high-fat diet-fed obese rats.

Aging Cell , 19, e Green tea polyphenol epigallocatechingallate alleviates nonalcoholic fatty liver disease and ameliorates intestinal immunity in mice fed a high-fat diet. Du, Y.

EpigallocatechinGallate Dampens Non-Alcoholic Fatty Liver by Modulating Liver Function, Lipid Profile and Macrophage Polarization. Nutrients , 13, Marseglia, L. Oxidative Stress in Obesity: A Critical Component in Human Diseases.

Chantre, P. Recent findings of green tea extract AR25 Exolise and its activity for the treatment of obesity. Phytomedicine , 9, 3—8. Kovacs, E. Effects of green tea on weight maintenance after body-weight loss. Nagao, T.

Ingestion of a tea rich in catechins leads to a reduction in body fat and malondialdehyde-modified LDL in men. Catechins are substances naturally present in green tea, the most abundant of which is epigallocatechin gallate EGCG.

In its safety assessment, EFSA looked at possible links between the consumption of EGCG in green tea infusions and food supplements and liver damage. Experts therefore considered catechins from green tea infusions brewed with hot water, and instant and ready-to-drink green tea beverages with similar catechin content, as generally safe.

Food supplements containing green tea catechins provide a daily EGCG intake The amount of a substance e. nutrient or chemical that is ingested by a person or animal via the diet.

ranging from mg. These food supplements are generally intended for adults. The average daily intake of EGCG resulting from the consumption of traditional green tea infusions ranges between 90 and mg, but may reach up to mg in adults who consume large quantities of these drinks.

Catechins in green tea extracts used in food supplements may be more concentrated, or have a different composition and pattern of consumption compared to catechins from green tea infusions.

For example, infusions tend to be consumed together with food and spread throughout the day, while supplements, especially for slimming, are more likely to be taken in a fasting state and as a single daily dose. Acute EGCG supplementation reverses endothelial dysfunction in patients with coronary artery disease.

J Am Coll Nutr ; 26 : 95— Hsu CH, Tsai TH, Kao YH, Hwang KC, Tseng TY, Chou P. Effect of green tea extract on obese women: a randomized, double-blind, placebo-controlled clinical trial. Clin Nutr ; 27 : — Shimizu M, Fukutomi Y, Ninomiya M, Nagura K, Kato T, Araki H et al.

Green tea extracts for the prevention of metachronous colorectal adenomas: a pilot study. Cancer Epidemiol Biomarkers Prev ; 17 : — Falsini B, Marangoni D, Salgarello T, Stifano G, Montrone L, Di Landro S et al.

Effect of epigallocatechin-gallate on inner retinal function in ocular hypertension and glaucoma: a short-term study by pattern electroretinogram. Graefes Arch Clin Exp Ophthalmol ; : — Janjua R, Munoz C, Gorell E, Rehmus W, Egbert B, Kern D et al.

A two-year, double-blind, randomized placebo-controlled trial of oral green tea polyphenols on the long-term clinical and histologic appearance of photoaging skin.

Dermatol Surg ; 35 : — Tsao AS, Liu D, Martin J, Tang XM, Lee JJ, El-Naggar AK et al. Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions. Cancer Prev Res Phila ; 2 : — Basu A, Sanchez K, Leyva MJ, Wu M, Betts NM, Aston CE et al.

Green tea supplementation affects body weight, lipids, and lipid peroxidation in obese subjects with metabolic syndrome. J Am Coll Nutr ; 29 : 31— Shen CL, Chyu MC, Pence BC, Yeh JK, Zhang Y, Felton CK et al.

Green tea polyphenols supplementation and Tai Chi exercise for postmenopausal osteopenic women: safety and quality of life report. BMC Complement Altern Med ; 10 : Thielecke F, Rahn G, Bohnke J, Adams F, Birkenfeld AL, Jordan J et al. Eur J Clin Nutr ; 64 : — Brown AL, Lane J, Holyoak C, Nicol B, Mayes AE, Dadd T.

Health effects of green tea catechins in overweight and obese men: a randomised controlled cross-over trial. Br J Nutr ; : — Hsu CH, Liao YL, Lin SC, Tsai TH, Huang CJ, Chou P. Does supplementation with green tea extract improve insulin resistance in obese type 2 diabetics?

A randomized, double-blind, and placebo-controlled clinical trial. Altern Med Rev ; 16 : — Hursel R, Westerterp-Plantenga MS. Consumption of milk-protein combined with green tea modulates diet-induced thermogenesis. Nutrients ; 3 : — Matsumoto K, Yamada H, Takuma N, Niino H, Sagesaka YM. Effects of green tea catechins and theanine on preventing influenza infection among healthcare workers: a randomized controlled trial.

BMC Complement Altern Med ; 11 : Ronzani G, Giaretta R, Morello M. Evaluation of oxidative stress and antioxidative action of green tea catechins in patients treated with tamoxifen: a randomized open-label, crossover study. Mediter J Nutr Metab ; 4 : — Crew KD, Brown P, Greenlee H, Bevers TB, Arun B, Hudis C et al.

Phase IB randomized, double-blinded, placebo-controlled, dose escalation study of polyphenon E in women with hormone receptor-negative breast cancer.

Cancer Prev Res Phila ; 5 : — Dash C, Chung FL, Rohan JA, Greenspan E, Christopher PD, Makambi K et al. A six-month crossover chemoprevention clinical trial of tea in smokers and non-smokers: methodological issues in a feasibility study.

BMC Complement Altern Med ; 12 : Loftis JM, Wilhelm CJ, Huckans M. Effect of epigallocatechin gallate supplementation in schizophrenia and bipolar disorder: an 8-week, randomized, double-blind, placebo-controlled study.

Ther Adv Psychopharmacol ; 3 : 21— Nguyen MM, Ahmann FR, Nagle RB, Hsu CH, Tangrea JA, Parnes HL et al. Randomized, double-blind, placebo-controlled trial of polyphenon E in prostate cancer patients before prostatectomy: evaluation of potential chemopreventive activities.

Yoshikawa T, Yamada H, Matsuda K, Niino H, Sagekawa YM, Kakuda T et al. Effects of short-term consumption of a large amount of tea catechins on chromosomal damage, oxidative stress markers, serum lipid, folic acid, and total homocysteine levels: a ramdomized, double-blind, controlled study.

Jpn J Clin Pharmacol Ther ; 43 : 9— Dryden GW, Lam A, Beatty K, Qazzaz HH, McClain CJ. A pilot study to evaluate the safety and efficacy of an oral dose of - -epigallocatechingallate-rich polyphenon E in patients with mild to moderate ulcerative colitis.

Inflamm Bowel Dis ; 19 : — PubMed Google Scholar. Roshdy E, Rajaratnam V, Maitra S, Sabry M, Allah AS, Al-Hendy A. Treatment of symptomatic uterine fibroids with green tea extract: a pilot randomized controlled clinical study.

Int J Womens Health ; 5 : — PubMed PubMed Central Google Scholar. Toolsee NA, Aruoma OI, Gunness TK, Kowlessur S, Dambala V, Murad F et al. Effectiveness of green tea in a randomized human cohort: relevance to diabetes and its complications.

Biomed Res Int ; : Ioannidis JP. Adverse events in randomized trials: neglected, restricted, distorted, and silenced. Pitrou I, Boutron I, Ahmad N, Ravaud P.

Reporting of safety results in published reports of randomized controlled trials. Ferner RE. Newly licensed drugs. Nagano J, Kono S, Preston DL, Mabuchi K. A prospective study of green tea consumption and cancer incidence, Hiroshima and Nagasaki Japan.

Cancer Causes Control ; 12 : — Inoue M, Kurahashi N, Iwasaki M, Shimazu T, Tanaka Y, Mizokami M et al. Effect of coffee and green tea consumption on the risk of liver cancer: cohort analysis by hepatitis virus infection status. Cancer Epidemiol Biomarkers Prev ; 18 : — Ui A, Kuriyama S, Kakizaki M, Sone T, Nakaya N, Ohmori-Matsuda K et al.

Green tea consumption and the risk of liver cancer in Japan: the Ohsaki Cohort study. Cancer Causes Control ; 20 : — Nechuta S, Shu XO, Li HL, Yang G, Ji BT, Xiang YB et al. Prospective cohort study of tea consumption and risk of digestive system cancers: results from the Shanghai Women's Health Study.

Am J Clin Nutr ; 96 : — Boehm K, Borrelli F, Ernst E, Habacher G, Hung SK, Milazzo S et al. Green tea Camellia sinensis for the prevention of cancer. Cochrane Database Syst Rev ; 3 : CD Jin X, Zheng RH, Li YM. Green tea consumption and liver disease: a systematic review.

Liver Int ; 28 : — Fon Sing M, Yang WS, Gao S, Gao J, Xiang YB. Epidemiological studies of the association between tea drinking and primary liver cancer: a meta-analysis. Eur J Cancer Prev ; 20 : — Stickel F, Kessebohm K, Weimann R, Seitz HK.

Review of liver injury associated with dietary supplements. Liver Int ; 31 : — Chalasani NP, Hayashi PH, Bonkovsky HL, Navarro VJ, Lee WM, Fontana RJ et al. ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury.

Am J Gastroenterol ; : — Download references. We thank all authors and investigators who provided detailed information for safety results. The funder had no role in study design, data collection and analysis, and in the decision to publish or prepare the manuscript.

Institute of Medical Science, Tokyo Medical University, Tokyo, Japan. Department of Public Health, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

Division of Biostatistics and Clinical Epidemiology, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan. You can also search for this author in PubMed Google Scholar. Correspondence to S Suzuki. TI is a founder and the chief executive of Clinical Study Support Inc.

TS and ST are current employees of Clinical Study Support Inc. MS and YM were previously employed by Clinical Study Support Inc.

TK is a member of an advisory board of the company. The remaining authors declare no conflict of interest. This work is licensed under a Creative Commons Attribution 4. Reprints and permissions. Isomura, T. et al. Liver-related safety assessment of green tea extracts in humans: a systematic review of randomized controlled trials.

Eur J Clin Nutr 70 , — Download citation. Received : 07 September Revised : 07 March Accepted : 11 March Published : 18 May Issue Date : November Anyone you share the following link with will be able to read this content:.

Sorry, a shareable link is not currently available for this article. Provided by the Springer Nature SharedIt content-sharing initiative.

European Journal of Clinical Nutrition Skip to main content Thank you for visiting nature. nature european journal of clinical nutrition review article.

Download PDF. Subjects Epidemiology. This article has been updated. Abstract There remain liver-related safety concerns, regarding potential hepatotoxicity in humans, induced by green tea intake, despite being supposedly beneficial.

Introduction Green tea is widely consumed in Asia, especially in Japan and China. Materials and methods A systematic review was conducted with reference to the following relevant guidelines: Preferred Reporting Items for Systematic Reviews and Meta-Analyses 13 and the Cochrane Handbook for Systematic Reviews of Interventions particularly on adverse events.

Data abstraction and quality assessment Data on adverse events related to the liver were extracted from the selected articles. Data analysis The odds ratio OR was used to assess the risk of liver-related adverse events associated with green tea interventions.

Results Literature search The database search returned PubMed articles, EMBASE articles and CENTRAL articles. Figure 1. Flowchart of study selection. Full size image. Table 1 Characteristics of selected studies Full size table. Figure 2. Risk of bias assessment. Table 2 Summary of reported liver-related adverse events Full size table.

Figure 3. Discussion In this review, liver-related safety of green tea intervention was assessed through a systematic review of published RCTs, allowing for a direct comparison with controls.

Change history 02 November This article has been corrected since Advance Online Publication and a corrigendum is also printed in this issue. References Katiyar S, Mukhtar H. CAS PubMed Google Scholar Henning SM, Fajardo-Lira C, Lee HW, Youssefian AA, Go VL, Heber D. Article CAS Google Scholar Sarma DN, Barrett ML, Chavez ML, Gardiner P, Ko R.

Dey and R. Bruno, in Dietary Liver health catechins with Liver health catechins Catechihs Understanding Mechanisms and Potential Health Benefitsed. Alasalvar, F. Shahidi, and C. Ho, The Royal Society of Chemistry,ch. Caatechins you catechlns visiting nature. Ehalth are using a Livver version with limited support for CSS. To Alternative medicine for diabetes the best experience, we recommend you Boost your metabolism a more up Liver health catechins date browser or turn off compatibility mode in Internet Explorer. In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript. A Corrigendum to this article was published on 02 November There remain liver-related safety concerns, regarding potential hepatotoxicity in humans, induced by green tea intake, despite being supposedly beneficial.